GLENMARK.NS
GLENMARK.NS
INE935A01035
GLENMARK PHARMACEUTICALS
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 167.114.030.000 131.458.360.000
27.1%
Cost of Revenue 51.139.070.000 47.573.420.000
7.5%
Gross Profit 115.974.960.000 83.884.940.000
38.3%
75.741.700.000 65.200.270.000
16.2%
Operating Income 40.233.260.000 18.684.670.000
115.3%
Pretax Income 19.847.460.000 13.992.090.000
41.8%
Net Income Common Stockholders 13.618.510.000 10.470.970.000
30.1%
-- --
--
-- --
--
ende